周向军
泌尿外科学
硕士生导师
硕士生导师
导师介绍
| 姓名 | 周向军 |
| 出生年月 | 1984年9月 |
| 单位 | 武汉大学人民医院泌尿外科 |
| 所属学科 | 临床医学-外科学 |
| 职务、职称及头衔 | 硕士生导师 |
| 24816439@qq.com | |
| 联系方式 | 027-88041911转81131或13554698769 |
| 研究方向 |
1.
肾结石的防治研究 2. 急性肾损伤与纤维化 |
| 个人简介 | 主要从事泌尿外科疾病的诊治与科研工作，获国家自然科学基金2项和参与5项。以第一作者和通讯作者发表SCI论文20余篇，单篇影响因子>10分2篇。多次在国内外肾脏病或泌尿外科年会上发言，参编专著1部。 |
| 学术任职与荣誉 | 湖北省临床肿瘤学组青年委员 |
| 教育履历 |
2004.09-2009.06湖北医药学院临床医学专业本科生获学士学位 2009.09-2012.06武汉大学第一临床学外科学硕士研究生获硕士学位 2012.09-2015.06武汉大学第一临床学院外科学博士研究生获博士学位 |
| 工作履历 |
2015.07-2020.12武汉大学人民医院泌尿外科主治医师 2015.09-2017.04美国佐治亚医学院访问学者 2020.12-至今武汉大学人民医院泌尿外科副主任医师 |
| 成果获奖 |
《肾结石微创治疗关键技术体系构建与临床应用》2022年湖北省科技进步一等奖 |
| 代表性论著 |
1.
Zhao S, Cheng F*,Zhou XJ*, et
al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics. 2021, 11(18)： 8660-8673. 2.Zhou XJ#, Zhao S#, Li W#, Cheng F, et al. Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo. Int J Biol Sci. 2021,17(14) ： 4021-4033. 3.Zhou XJ#，Li YW#， Wu C，Cheng F. Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1. Renal failure. 2020, 42(1): 994–1003. 4. Li BJ , Xia YQ, Mei SQ,Zhou XJ*, Cheng F*.Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI. Theranostics. 2023,13(6):1860-1875. 5. Ye ZH , Xia YQ, Li L,Zhou XJ*, Fan Cheng F * . p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis. Biomed Pharmacother. 2023,164:114925. |
| Name | XIANGJUN ZHOU |
| Date of birth | Sep，1984 |
| Department | Urology Department，Renmin Hospital,Wuhan University. |
| Title | Professor |
| 24816439@qq.com | |
| TEL | 027-88041911-81131 or 13554698769 |
| Research Direction |
1.
Prevention and treatment of Kidney stone disease 2. Acute kidney injury and fibrosis |
| Personal Profile | He is mainly engaged in the diagnosis, treatment and scientific research of Urology diseases, and has won two National Natural Science Foundation projects and participated in five projects. Published over 20 SCI papers as the first author and corresponding author, with 2 papers with a single impact factor greater than 10 points. He has spoken at the annual meeting of nephrology or Urology at home and abroad for many times and participated in editing one monograph. |
| Selected Publications |
1.
Zhao S, Cheng F*, Zhou XJ*, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics. 2021, 11(18)： 8660-8673. 2. Zhou XJ#, Zhao S#, Li W#, Cheng F, et al. Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo. Int J Biol Sci. 2021,17(14) ： 4021-4033. 3. Zhou XJ#， Li YW#， Wu C，Cheng F. Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1. Renal failure. 2020, 42(1): 994–1003. 4. Li BJ , Xia YQ, Mei SQ, Zhou XJ* , Cheng F*.Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI. Theranostics. 2023,13(6):1860-1875. 5. Ye ZH , Xia YQ, Li L, Zhou XJ* , Fan Cheng F * . p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis. Biomed Pharmacother. 2023,164:114925. |
武汉大学人民医院
湖北省人民医院